OPIOIDS AND PUBLIC HEALTH
Last Updated: Mar 28, 2016
- The CDC Guideline on Opioid Prescribing- Rising to the Challenge
Y. Olson, JAMA, March, 2016 - CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
MMWR, March 15, 2016 - Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline information for codeine and CYP2D6
PharmGKB, January 2016 - Professional Society (PRO) guideline information for codeine and CYP2D6
PharmGKB, 2016 - What does addiction medicine expect from neuroscience? From genes and neurons to treatment responses.
Le Foll Bernard et al. Progress in brain research 2016 419-47 - The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review.
Baber Marta et al. Pharmacogenomics 2016 Jan (1) 75-93 - The Influence of Genotype Polymorphism on Morphine Analgesic Effect for Postoperative Pain in Children.
Lee Mi Geum, et al. The Korean journal of pain 2016 1 (1) 34-9 - Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers.
Meshkin Brian et al. International journal of biomedical science : IJBS 2015 Dec 11(4) 157-65 - Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
Bell Gillian C, et al. Cancer control : journal of the Moffitt Cancer Center 2015 10 (4) 426-32 - Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme.
Puymirat Etienne, et al. European heart journal 2015 11 - Morphine-induced anti-nociception and reward in "humanized" mice expressing the mu opioid receptor A118G polymorphism.
Henderson-Redmond Angela N, et al. Brain research bulletin 2015 10 - Acute pain Factors predictive of post-operative pain and opioid requirement in multimodal analgesia following knee replacement.
Thomazeau J, et al. European journal of pain (London, England) 2015 10 - [M1-OPIOID RECEPTOR AND CATECHOL-O-METILTRANSFERASE GENES POLYMORPHISM EFFECTS ON PERIOPERATIVE PSYCHOLOGICAL CONDITION OF THE PATIENTS AND THE EFFECTIVENESS OF POSTOPERATIVE ANALGESIA WITH OPIOIDS].
Potapov A L, et al. Anesteziologiia i reanimatologiia 0 0 (3) 48-51 - Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
Siegenthaler Andreas, et al. BMC pharmacology & toxicology 2015 0 (1) 23 - Event-related potentials in performance monitoring are influenced by the endogenous opioid system.
Pfabigan Daniela M, et al. Neuropsychologia 2015 9 242-252 - Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl.
Barratt Daniel T, et al. PloS one 2015 0 (9) e0137179 - Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Published on 2014 by Expert group - KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
Johnson Eric O, et al. Addiction biology 2015 7 - [Genetic polymorphisms commonly influencing efficacy of diverse addictive substances].
Nishizawa Daisuke, et al. Nihon Aruk?ru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 2014 4 (2) 83-91 - [Genetic polymorphisms commonly associated with sensitivity to various addictive substances].
Nishizawa Daisuke, et al. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 2013 11 (5-6) 205-9 - OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis.
Hwang In Cheol, et al. Anesthesiology 2014 10 (4) 825-34 - ?-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer.
Cie?li?ska Anna, et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 6 (6) 4655-60 - Prediction formulas for individual opioid analgesic requirements based on genetic polymorphism analyses.
Yoshida Kaori, et al. PloS one 2015 0 (1) e0116885 - Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects.
Sadhasivam S, et al. The pharmacogenomics journal 2015 10 (5) 436-42 - Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment.
Seripa Davide, et al. Pain medicine (Malden, Mass.) 2015 5 - Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors?
Currow David C, et al. BMJ open 2015 0 (5) e006818 - Genetic and Non-genetic Factors Associated With Constipation in Cancer Patients Receiving Opioids.
Laugsand Eivor A, et al. Clinical and translational gastroenterology 2015 0 e90 - Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism.
Robinson J Elliott, et al. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2015 10 (11) 2614-22 - ?-Opioid Receptor Gene A118 G Variants and Persistent Pain Symptoms Among Men and Women Experiencing Motor Vehicle Collision.
Linnstaedt Sarah D, et al. The journal of pain : official journal of the American Pain Society 2015 7 (7) 637-44 - [Impact of genetic factors on severity of side effects of opioids in patients after major surgical interventions].
Boiarkina A V, et al. Klinichna khirurhiia / Ministerstvo okhorony zdorov'ia Ukraïny, Naukove tovarystvo khirurhiv Ukraïny 2014 5 (5) 52-5
- CDC Web Information (1)
- CDC-Authored Genomics Publications (0)
- Hot Topics (8)
- Genomics & Health Impact Scan (0)
- AMD Weekly Clips (0)
- HuGE (85)
- AMD Weekly Clips (0)
- Guidelines (1)
- Evidence Classification (0)
- Weekly Scan (1)
.png)
No hay comentarios:
Publicar un comentario